Kala制药(KALA)

3.0325 -0.3175 -9.4776%

今开:2.8565昨收:3.35
最高:3.04 最低:2.75
涨停价:0.0跌停价:0.0
总市值:1.96027972E8

Kala制药的热门评论

Takeabreak06-18 22:39

$安帝君斯(AGEN)$ $Kala制药(KALA)$ $Affimed(AFMD)$ BCYC, CGEN 这些都很强势!守住不动,同时间 XBI往下0.8%+。AMRS更是往上1%。吹票时间到了!![加油]查看全文

Spica07-18 19:54

回复@Takeabreak: 我问了下一位做干眼症的朋友,他是这么回复的“”Eysuvis 应该还不错,但不会成为重磅。重要的原因:lotemax一直被off label用作治疗干眼,$Kala制药(KALA)$ 只是改了一个剂型,把off label变成approved。Lotemax医生可以随便开的,会一定程度限制了Eysuvis销售“//@Takeabreak:...查看全文

Takeabreak07-26 21:10

$Kala制药(KALA)$ Symphony Health sales and volume estimates are as follows: For the week ending July 16, 2021: INVELTYS: Approximately $828k (MBS Dollars) in sales and 2,985 pack units (both up +20.7% week-over-week) -About 74% were from new prescriptions and 26% from refill...查看全文

Takeabreak07-22 11:50

$Karyopharm(KPTI)$ $G1治疗(GTHX)$ $Kala制药(KALA)$ BTAI. Value destroyers?? Commercialization is more risky. Lesson learned??? Or patience is a virtue ??查看全文

Takeabreak06-07 22:17

$Kala制药(KALA)$ 出坑了!! 1. 天热了, 要开空调了, 干眼症要爆发了! 2. 疫苗都打好了, 该找医生的要去找医生了! 看到有竟然目标价设40刀的!!!查看全文

7X24快讯06-08 00:02

美股纳米生物概念股集体上涨,Arbutus生物制药涨超17%,太平洋生物科技涨超7%,剪头制药、诺瓦瓦克斯医药涨超5%,Selecta生物科学、Kala制药涨超4%。查看全文

Takeabreak05-07 11:19

$Kala制药(KALA)$ 6刀5刀分别加了,浮亏较大。KPTI,BTAI,GTHX 也都不行,好在轻仓,确实只能是value play查看全文

Takeabreak04-23 21:56

$Kala制药(KALA)$ 重新站上8刀。财报有花头。今年目标15刀查看全文

Kala制药(KALA)05-06 04:06

$Kala制药(KALA)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-21-005904 Act: 34 Size: 6 MB 网页链接查看全文

美股市场有望回暖,这两只小摩所选股真能直冲云霄?

美股研究社04-15 17:24

本文作者:Marty Shtrubel 根据摩根大通首席执行官杰米•戴蒙(Jamie Dimon)的说法,美国正处于经济繁荣的风口浪尖,这种繁荣至少可以推动到2023年。戴蒙将强劲增长的前景归因于几个原因。 戴蒙表示:“我毫不怀疑,随着过度储蓄、新的刺激性储蓄、巨额赤字支出、更多的量化宽松政策、新的潜在基础...查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Kala制药的最新评论

Takeabreak03-18 23:18

$阿米瑞斯(AMRS)$ $Affimed(AFMD)$ 2位都是中场休息几日。其余的表现今天都可以,尤其是XBI -1.5%的日子里。$Kala制药(KALA)$ BCYC, HOOK, CRIS; 还在地板上的有 AGEN,GTHX。 EVGN昨日下探,顺势抢了一点,希望继续往下。查看全文

Takeabreak03-16 23:21

$Kala制药(KALA)$ “We are pleased to announce the addition of EYSUVIS to Cigna’s preferred formulary, reflecting a significant expansion of our commercial coverage and important progress toward our goal of securing broad patient access,” said Todd Bazemore, Chief Operating...查看全文

Takeabreak03-08 12:02

$Kala制药(KALA)$ volume estimates for the week ending February 26, 2021 was: Inveltys: Approximately $832k (MBS Dollars) in sales and 3,000 pack units (both up +15.6% week-over-week). Eysuvis: Approximately $345k (MBS Dollars) in sales and 744 pack units (both up +50% week-o...查看全文

Takeabreak03-06 01:06

$工艺酿酒联盟(HOOK)$ 今天你太亮了,BIO持仓中最靓的仔。跌幅最大的是$Evogene(EVGN)$ 还有$Kala制药(KALA)$ MDNA.......查看全文

Kala制药(KALA)03-04 06:18

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-21-002694 Size: 6 KB 网页链接查看全文

Takeabreak03-03 23:39

$Kala制药(KALA)$ 前面莫名其妙的跌多了......$工艺酿酒联盟(HOOK)$ 独立走势[涨]查看全文

Takeabreak03-03 22:39

$Kala制药(KALA)$ KALA Kala recent selloff brings attractive entry point, says JPMorgan JPMorgan analyst Christopher Neyor says the recent pullback in shares of Kala Pharmaceuticals provides an attractive entry point. With the company's lead asset Eysuvis in an early stag...查看全文

Kala制药(KALA)03-02 19:21

$Kala制药(KALA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000947871-21-000277 Act: 34 Size: 83 KB 网页链接查看全文

Kala制药(KALA)02-27 07:33

$Kala制药(KALA)$ 内部交易: 2021-02-25,Chief Scientific Officer,Chen Hongming ,期权,47000普通股, $2.30查看全文

Kala制药(KALA)02-27 06:51

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-21-002366 Size: 6 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Kala制药的公告

当期报告

$Kala制药(KALA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-21-010375 Act: 34 Size: 385 KB 网页链接

$Kala制药(KALA)$ 内部交易: 2021-06-29,CHIEF SCIENTIFIC OFFICER,Chen Hongming ,卖出,5548普通股, $5.56

持股变动声明

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-21-003271 Size: 5 KB 网页链接

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF EXECUTIVE OFFICER,Iwicki Mark T ,卖出,7586普通股, $5.77

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF FINANCIAL OFFICER,Reumuth Mary ,卖出,2452普通股, $5.77

$Kala制药(KALA)$ 内部交易: 2021-06-28,SEE REMARKS,Trachtenberg Eric ,卖出,2452普通股, $5.77

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF MEDICAL OFFICER,Brazzell Romulus K ,卖出,3034普通股, $5.77

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF SCIENTIFIC OFFICER,Chen Hongming ,卖出,2452普通股, $5.77

持股变动声明

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-21-003256 Size: 4 KB 网页链接

持股变动声明

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-21-003257 Size: 5 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24